Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of infringing were invalid.
Florida first lady Casey DeSantis called out the CDC for continuing to recommend COVID-19 vaccines for children beginning at ...
Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and ...
COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...
1don MSN
Officials say roughly 650 Marines and Army soldiers who were forced out of the military for refusing to get the COVID-19 ...
The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...
The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...
Five years after the COVID-19 pandemic began, thousands of Dutch citizens report regretting their decision to get vaccinated.
The St. Louis Board of Education adopted a vaccine mandate in fall of 2021 for all SLPS staff without a medical or religious ...
The COVID-19 vaccine has prompted more than 10 times as many reports of adverse symptoms than the measles vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback